All hospital roles and robotics team members are encouraged to attend.
If you’re interested in attending an Enrich program, please contact executive.education@intusurg.com.
Program Speakers
Dr. Allyson Brooks, Chief Quality Officer
Dr. Jeb Brown, Gynecologic Oncologist
Diane Amaral, Manager, Operating Room and Robotic Coordinator
Jorge Rojas, Financial Analyst
Program Speakers
Carlos Carrasco, Chief Operating Officer
Jeanne Cannon, Nursing Operations Manager
Desrene Gibson, Robotic Assistant Nurse Manager
Amanda Maldonado, Service Line Marketing Manager
Dr. Veronica Schimp, Robotics Medical Director
Allen Rice, Data Analyst
Program Speakers
Mark Sparta, President
Dr. Ihor Sawczuk, President Northern Region
Dr. Michael Stifelman, Chair of Urology and Director of Robotic Surgery
Terri Freguletti, Vice President, Perioperative Services
Vivian Kufour, Robotic Surgery Clinical Coordinator
Program Speakers
Susan McDonald, Vice President & Chief Nursing Officer
David Vine, Director, Perioperative Business Operations
Dr. Michael Davenport, Chairman of Robotic Steering Committee
Carolyn Reusch, System-wide Robotics Coordinator
Program Speakers
Mary Bakken, Executive Vice President, Chief Operating Officer
Dr. Thai Nguyen, Urologic Surgeon
Marybeth Antone, Associate Vice President, Operations
Nikki Banda, Robotic Coordinator
Financial disclosure
The independent surgeons mentioned on this website have received compensation from Intuitive for consulting and/or educational services.
Presenter disclaimer
The material presented represents the views and opinions of independent surgeons based on their practice and personal experience performing surgery with the da Vinci surgical system. Their experience may or may not be reproducible and is not generalizable.
Important safety information
Patients should talk to their doctor to decide if da Vinci surgery is right for them. Patients and doctors should review all available information on non-surgical and surgical options and associated risks in order to make an informed decision.
Serious complications may occur in any surgery, including da Vinci surgery, up to and including death. Serious risks include, but are not limited to, injury to tissues and organs and conversion to other surgical techniques which could result in a longer operative time and/or increased complications. For Important Safety Information, including surgical risks, indications, and considerations and contraindications for use, please also refer to www.intuitive.com/safety.
Individuals' outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience.